Benitec Biopharma Inc.
BNTC
$14.61
-$0.33-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 0.00 | -3.00K |
| Gross Profit | -- | -- | -- | 0.00 | 3.00K |
| SG&A Expenses | 4.21M | 3.54M | 2.21M | 2.04M | 1.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.19M | 8.61M | 5.79M | 5.55M | 4.14M |
| Operating Income | -10.19M | -8.61M | -5.79M | -5.55M | -4.14M |
| Income Before Tax | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M |
| EBIT | -10.19M | -8.61M | -5.79M | -5.55M | -4.14M |
| EBITDA | -10.18M | -8.60M | -5.77M | -5.52M | -4.12M |
| EPS Basic | -0.24 | -0.33 | -0.48 | -0.60 | -0.23 |
| Normalized Basic EPS | -0.15 | -0.21 | -0.30 | -0.33 | -0.15 |
| EPS Diluted | -0.24 | -0.33 | -0.48 | -0.60 | -0.23 |
| Normalized Diluted EPS | -0.15 | -0.21 | -0.30 | -0.33 | -0.15 |
| Average Basic Shares Outstanding | 38.60M | 22.08M | 10.64M | 8.89M | 18.28M |
| Average Diluted Shares Outstanding | 38.60M | 22.08M | 10.64M | 8.89M | 18.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |